{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:29:19Z","timestamp":1785522559086,"version":"3.56.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.biopha.2024.116204","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T01:54:51Z","timestamp":1707962091000},"page":"116204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Emerging role and mechanism of HACE1 in the pathogenesis of neurodegenerative diseases: A promising target"],"prefix":"10.1016","volume":"172","author":[{"given":"Caixia","family":"Zang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyu","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2024.116204_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11481-017-9725-x","article-title":"Nanomedicines for the treatment of CNS diseases","volume":"12","author":"Reynolds","year":"2017","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.biopha.2024.116204_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.irn.2016.05.002","article-title":"Recent trends in nanotechnology toward CNS diseases: lipid-based nanoparticles and exosomes for targeted therapeutic delivery","volume":"130","author":"Cardoso","year":"2016","journal-title":"Int. Rev. Neurobiol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116204_bib3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.drudis.2017.11.010","article-title":"Personalized nanomedicine for CNS diseases","volume":"23","author":"Kaushik","year":"2018","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.biopha.2024.116204_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12325-019-01148-5","article-title":"Pathophysiology and therapeutic perspectives of oxidative stress and neurodegenerative diseases: a narrative review","volume":"37","author":"Rekatsina","year":"2020","journal-title":"Adv. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2024.116204_bib5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/15548627.2021.1936359","article-title":"Targeting autophagy in disease: established and new strategies","volume":"18","author":"Kocak","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2024.116204_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105101","article-title":"Long non-coding RNA: an underlying bridge linking neuroinflammation and central nervous system diseases","volume":"148","author":"Chen","year":"2021","journal-title":"Neurochem. Int."},{"issue":"8","key":"10.1016\/j.biopha.2024.116204_bib7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1089\/ars.2020.8134","article-title":"Preventive and therapeutic strategies in Alzheimer's disease: focus on oxidative stress, redox metals, and ferroptosis","volume":"34","author":"Plascencia-Villa","year":"2021","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2024.116204_bib8","first-page":"6137521","article-title":"Oxidative stress and neuroinflammation potentiate each other to promote progression of dopamine","volume":"2020","author":"He","year":"2020","journal-title":"Neurodegener. Oxid. Med. Cell. Longev."},{"issue":"44","key":"10.1016\/j.biopha.2024.116204_bib9","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107663118","article-title":"d-mannose suppresses oxidative response and blocks phagocytosis in experimental neuroinflammation","volume":"118","author":"Wang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2024.116204_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107907","article-title":"Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury","volume":"172","author":"Eastman","year":"2020","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116204_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbamcr.2013.03.024","article-title":"Mammalian HECT ubiquitin-protein ligases: biological and pathophysiological aspects","volume":"1843","author":"Scheffner","year":"2014","journal-title":"Biochim. Et. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.biopha.2024.116204_bib12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41401-021-00778-2","article-title":"HACE1 negatively regulates neuroinflammation through ubiquitylating and degrading Rac1 in Parkinson's disease models","volume":"43","author":"Zang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.biopha.2024.116204_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/hmg\/ddx394","article-title":"HACE1 is essential for astrocyte mitochondrial function and influences Huntington disease phenotypes in vivo","volume":"27","author":"Ehrnhoefer","year":"2018","journal-title":"Hum. Mol. Genet"},{"issue":"3","key":"10.1016\/j.biopha.2024.116204_bib14","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000330","article-title":"HACE1 deficiency leads to structural and functional neurodevelopmental defects","volume":"5","author":"Nagy","year":"2019","journal-title":"Neurol. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2024.116204_bib15","article-title":"Bayesian cox proportional hazards model in survival analysis of HACE1 gene with age at onset of Alzheimer's disease","volume":"3","author":"Wang","year":"2017","journal-title":"Int. J. Clin. Biostat. Biom."},{"issue":"10","key":"10.1016\/j.biopha.2024.116204_bib16","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.2174\/1389450120666190227184654","article-title":"Loss of the tumor suppressor HACE1 contributes to cancer progression","volume":"20","author":"Li","year":"2019","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.biopha.2024.116204_bib17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington's disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116204_bib18","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41467-021-21637-y","article-title":"Mutant Huntingtin stalls ribosomes and represses protein synthesis in a cellular model of Huntington disease","volume":"12","author":"Eshraghi","year":"2021","journal-title":"Nat. Commun."},{"issue":"18","key":"10.1016\/j.biopha.2024.116204_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221810041","article-title":"Oxidative stress and NADPH oxidase: connecting electromagnetic fields, cation channels and biological effects","volume":"22","author":"Georgiou","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116204_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrrev.2021.108365","article-title":"Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer","volume":"787","author":"Caliri","year":"2021","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"issue":"9","key":"10.1016\/j.biopha.2024.116204_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092090","article-title":"Oxidative stress in Cardiovascular diseases: still a therapeutic target?","volume":"11","author":"Senoner","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.biopha.2024.116204_bib22","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3233\/JAD-170732","article-title":"A long journey into aging, brain aging, and Alzheimer's disease following the oxidative stress tracks","volume":"62","author":"Mecocci","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.biopha.2024.116204_bib23","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1089\/ars.2019.8004","article-title":"Mitochondrial and redox-based therapeutic strategies in Huntington's disease","volume":"34","author":"F\u00e3o","year":"2021","journal-title":"Antioxid. Redox Signal"},{"issue":"3","key":"10.1016\/j.biopha.2024.116204_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JHD-160205","article-title":"Oxidative stress and Huntington's disease: the good, the bad, and the ugly","volume":"5","author":"Kumar","year":"2016","journal-title":"J. Huntingt. Dis."},{"issue":"8","key":"10.1016\/j.biopha.2024.116204_bib25","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1073\/pnas.1314421111","article-title":"HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response","volume":"111","author":"Rotblat","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2024.116204_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41392-021-00793-z","article-title":"HACE1-mediated NRF2 activation causes enhanced malignant phenotypes and decreased radiosensitivity of glioma cells","volume":"6","author":"Da","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"23","key":"10.1016\/j.biopha.2024.116204_bib27","doi-asserted-by":"crossref","first-page":"13888","DOI":"10.18632\/aging.205272","article-title":"HACE1 expression in heart failure patients might promote mitochondrial oxidative stress and ferroptosis by targeting NRF2","volume":"15","author":"Yin","year":"2023","journal-title":"Aging"},{"issue":"9","key":"10.1016\/j.biopha.2024.116204_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01812-18","article-title":"HACE1, an E3 Ubiquitin protein ligase, mitigates Kaposi's sarcoma-associated herpesvirus infection-induced oxidative stress by promoting Nrf2 activity","volume":"93","author":"Kumar","year":"2019","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116204_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3233\/JHD-180311","article-title":"Rac1 activity is modulated by Huntingtin and dysregulated in models of Huntington's disease","volume":"8","author":"Tousley","year":"2019","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.biopha.2024.116204_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.neuroscience.2011.11.059","article-title":"Cell type-specific localization of optineurin in the striatal neurons of mice: implications for neuronal vulnerability in Huntington's disease","volume":"202","author":"Okita","year":"2012","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.biopha.2024.116204_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neulet.2011.10.070","article-title":"Optineurin in Huntington's disease intranuclear inclusions","volume":"506","author":"Schwab","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2024.116204_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","article-title":"Alzheimer's disease","volume":"167","author":"Soria Lopez","year":"2019","journal-title":"Handb. Clin. Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116204_bib33","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.ygeno.2020.01.015","article-title":"The relationship between the minor allele content and Alzheimer's disease","volume":"112","author":"Chen","year":"2020","journal-title":"Genomics"},{"issue":"4","key":"10.1016\/j.biopha.2024.116204_bib34","first-page":"347","article-title":"Alzheimer's disease: clinical update on epidemiology, pathophysiology and diagnosis","volume":"26","author":"Eratne","year":"2018","journal-title":"Australas. Psychiatry. Bull. R. Aust. N. Z. Coll. Psychiatr."},{"key":"10.1016\/j.biopha.2024.116204_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2015.11.003","article-title":"Nrf2-ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases","volume":"157","author":"Buendia","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2024.116204_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111817","article-title":"Flavonoids targeting NRF2 in neurodegenerative disorders","volume":"146","author":"Khan","year":"2020","journal-title":"Food Chem. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116204_bib37","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.neurobiolaging.2014.09.004","article-title":"Increased Alzheimer's disease\u2013like pathology in the APP\/ PS1\u0394E9 mouse model lacking Nrf2 through modulation of autophagy","volume":"36","author":"Joshi","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.biopha.2024.116204_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081884","article-title":"Role of Nrf2 in synaptic plasticity and memory in Alzheimer\u2019s disease","author":"Davies","year":"2021","journal-title":"Cells"},{"issue":"13","key":"10.1016\/j.biopha.2024.116204_bib39","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/onc.2012.189","article-title":"The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation","volume":"32","author":"Castillo-Lluva","year":"2013","journal-title":"Oncogene"},{"issue":"19","key":"10.1016\/j.biopha.2024.116204_bib40","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1038\/s41388-019-0676-y","article-title":"Oxygen sensor FIH inhibits HACE1-dependent ubiquitination of Rac1 to enhance metastatic potential in breast cancer cells","volume":"38","author":"Kim","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2024.116204_bib41","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/ncomms3180","article-title":"Hace1 controls ROS generation of vertebrate Rac1-dependent NADPH oxidase complexes","volume":"4","author":"Daugaard","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116204_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fnsyn.2020.00012","article-title":"The role of rac GTPase in dendritic spine morphogenesis and memory","volume":"12","author":"Costa","year":"2020","journal-title":"Front Synaptic Neurosci."},{"key":"10.1016\/j.biopha.2024.116204_bib43","article-title":"Rho signaling in synaptic plasticity, memory, and brain disorders","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.biopha.2024.116204_bib44","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s13238-019-0641-0","article-title":"Inhibition of Rac1-dependent forgetting alleviates memory deficits in animal models of Alzheimer's disease","volume":"10","author":"Wu","year":"2019","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.biopha.2024.116204_bib45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/15548627.2021.1908722","article-title":"Emerging views of OPTN (optineurin) function in the autophagic process associated with disease","volume":"18","author":"Qiu","year":"2022","journal-title":"Autophagy"},{"issue":"24","key":"10.1016\/j.biopha.2024.116204_bib46","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025053118","article-title":"ALS- and FTD-associated missense mutations in TBK1 differentially disrupt mitophagy","volume":"118","author":"Harding","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2024.116204_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12974-021-02327-4","article-title":"Downregulating expression of OPTN elevates neuroinflammation via AIM2 inflammasome- and RIPK1-activating mechanisms in APP\/PS1 transgenic mice","volume":"18","author":"Cao","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2024.116204_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110462","article-title":"Targeting autophagy receptors OPTN and SQSTM1 as a novel therapeutic strategy for osteoporosis complicated with Alzheimer's disease","volume":"377","author":"Duan","year":"2023","journal-title":"Chem. Biol. Inter."},{"issue":"2","key":"10.1016\/j.biopha.2024.116204_bib49","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","article-title":"Parkinson's disease","volume":"103","author":"Reich","year":"2019","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.biopha.2024.116204_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lfs.2019.03.057","article-title":"Parkinson's disease: mechanisms, translational models and management strategies","volume":"226","author":"Raza","year":"2019","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.biopha.2024.116204_bib51","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13031","article-title":"Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.biopha.2024.116204_bib52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis. 109(Pt B)"},{"issue":"7","key":"10.1016\/j.biopha.2024.116204_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/genes12071006","article-title":"The genetics of Parkinson's disease and implications for clinical practice","volume":"12","author":"Day","year":"2021","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.biopha.2024.116204_bib54","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13024-017-0225-5","article-title":"NADPH oxidases in Parkinson's disease: a systematic review","volume":"12","author":"Belarbi","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.biopha.2024.116204_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010198","article-title":"HPV-mediated resistance to TNF and TRAIL is characterized by global alterations in apoptosis regulatory factors, dysregulation of death receptors, and induction of ROS\/RNS","volume":"20","author":"Cabe\u00e7a","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116204_bib56","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41467-020-20828-3","article-title":"Structural insights into the disruption of TNF-TNFR1 signalling by small molecules stabilising a distorted TNF","volume":"12","author":"McMillan","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.biopha.2024.116204_bib57","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.celrep.2016.04.032","article-title":"The tumor suppressor hace1 is a critical regulator of TNFR1-mediated cell fate","volume":"15","author":"Tortola","year":"2016","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.biopha.2024.116204_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/v8050146","article-title":"HACE1 negatively regulates virus-triggered type I IFN signaling by impeding the formation of the MAVS-TRAF3 complex","volume":"8","author":"Mao","year":"2016","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.biopha.2024.116204_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11010026","article-title":"NRF2 activation ameliorates oxidative stress and improves mitochondrial function and synaptic plasticity, and in A53T \u03b1-synuclein hippocampal neurons","volume":"11","author":"Brandes","year":"2021","journal-title":"Antioxidants"},{"issue":"8","key":"10.1016\/j.biopha.2024.116204_bib60","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/ars.2016.6800","article-title":"The neuroprotective effect of dimethyl fumarate in an MPTP-mouse model of Parkinson's disease: involvement of reactive oxygen species\/nuclear factor-\u03baB\/nuclear transcription factor related to NF-E2","volume":"27","author":"Campolo","year":"2017","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2024.116204_bib61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2014.11.047","article-title":"Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity","volume":"286","author":"Jing","year":"2015","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.biopha.2024.116204_bib62","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/toxsci\/kfw133","article-title":"From the cover: alterations in optineurin expression and localization in pre-clinical Parkinson's disease models","volume":"153","author":"Wise, Jr","year":"2016","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2024.116204_bib63","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ymthe.2006.06.009","article-title":"Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease","volume":"14","author":"Vercammen","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2024.116204_bib64","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.expneurol.2013.01.001","article-title":"Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity","volume":"247","author":"Liu","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2024.116204_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117322","article-title":"Parkin overexpression attenuates A\u03b2-induced mitochondrial dysfunction in HEK293 cells by restoring impaired mitophagy","volume":"244","author":"Wang","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116204_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.581","article-title":"PINK1-induced mitophagy promotes neuroprotection in Huntington's disease","volume":"6","author":"Khalil","year":"2015","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.biopha.2024.116204_bib67","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224000854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224000854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:51:35Z","timestamp":1760104295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224000854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":67,"alternative-id":["S0753332224000854"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116204","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging role and mechanism of HACE1 in the pathogenesis of neurodegenerative diseases: A promising target","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116204"}}